Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome

Cyclic Vomiting Syndrome Clinical Trial

Official title:
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Staccato Granisetron (AZ-010) for the Acute Treatment of Moderate to Severe Cyclic Vomiting Syndrome

Status Completed

Clinical Trial Summary

This is a multicenter, randomized, double-blind, parallel group, placebo-controlled, efficacy and safety study of adult outpatients diagnosed with CVS and experiencing recurring episodes of stereotypical vomiting.

Clinical Trial Description

A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Staccato Granisetron (AZ-010) for the Acute Treatment of Moderate to Severe Cyclic Vomiting Syndrome ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04645953
Study type	Interventional
Source	Alexza Pharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	February 11, 2021
Completion date	July 19, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04329637` - Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS	N/A
Withdrawn	`NCT00728104` - The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)	N/A
Recruiting	`NCT05256160` - Cortical Excitability in Cyclic Vomiting Syndrome	N/A
Recruiting	`NCT05961995` - Heartfulness Meditation Cyclic Vomiting Syndrome	N/A
Completed	`NCT03434652` - Auricular Neurostimulation for Cyclic Vomiting Syndrome	N/A
Completed	`NCT03470181` - Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
Completed	`NCT03295760` - Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children	N/A
Terminated	`NCT05065567` - Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis	Phase 2
Terminated	`NCT04721171` - Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.	N/A